Standard BioTools Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $153.6M | $21.7M |
| FY2020 | — | $139.1M | $68.5M |
| FY2021 | — | $94.6M | $28.5M |
| FY2022 | $64.9M | $-81.5M | $81.3M |
| FY2023 | $63.5M | $-148.1M | $51.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $153.6M | $21.7M |
| FY2020 | — | $139.1M | $68.5M |
| FY2021 | — | $94.6M | $28.5M |
| FY2022 | $64.9M | $-81.5M | $81.3M |
| FY2023 | $63.5M | $-148.1M | $51.7M |